Isomark Health

About:

Isomark is a developer of infection detection to improve the health of production animals.

Website: http://isomark.com

Twitter/X: Isomarkbreath

Top Investors: Wisconsin Alumni Research Foundation, Johnsonville Sausage, Innova Memphis

Description:

Isomark is a developer of a patented, non-invasive technology to monitor animal health and disease states by measuring and analyzing isotopic biomarkers through exhaled CO2 samples. The company's technology rapidly measures a patented set of breath biomarkers for detecting the presence of infection in as little as 30 seconds. Presently, 1 million beef cattle are at risk of bovine respiratory diseases in the United States contracting lung infections annually leading to $1 billion in losses due to mortality and morbidity. Isomark’s non-invasive technology also can provide real-time results at the Chute site, in contrast to current diagnostic tests which require hours or days for laboratory analysis. Isomark's technology saves significant costs due to care and drugs specifically help reduce the use of antibiotics thus improving meat quality for consumers.

Total Funding Amount:

$3.19M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)isomark.com

Founders:

Fariba Assadi Porter, Hamid R. Eghbalnia, Marco Tonelli, Mark E. Cook, Michael R. Shortreed, Warren P Porter

Number of Employees:

1-10

Last Funding Date:

2022-12-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai